The question sits at the centre of every serious altitude buyer's decision. Is simulated altitude as good as real altitude? The honest answer is grounded in research that has tested the two head to head in elite athletes. Hbmass response is similar. Performance outcomes are similar. Some marginal physiological differences exist around the edges, but they do not translate into meaningful performance gaps when the dose is properly matched.

This article walks through what the research actually shows, where the modalities differ, and why the lifestyle reality of normobaric hypoxia at home is what makes serious altitude training accessible to anyone outside the elite touring class.

What Is the Difference?

Real altitude is hypobaric hypoxia. The atmosphere at 2,500m has both a lower fraction of oxygen available to the lungs and a lower total atmospheric pressure pushing that oxygen across the alveolar membrane. The combined effect is reduced oxygen delivery to the bloodstream.

Simulated altitude in homes, hypoxic apartments, and altitude tents is normobaric hypoxia. Atmospheric pressure stays at sea level. The fraction of oxygen in the breathed air is reduced through nitrogen dilution, oxygen extraction, or membrane filtration. The partial pressure of oxygen entering the lungs is matched to the equivalent natural altitude.

This is the technical basis of the question. Both modalities reduce inspired oxygen partial pressure (PiO2). They achieve it through different physical mechanisms.

How does each condition affect the body?

The physiological response is largely shared. Both modalities trigger the kidneys to release erythropoietin (EPO). Both stimulate erythropoiesis in the bone marrow. Both produce a measurable Hbmass response across a properly dosed block.

Some marginal differences exist. Hypobaric hypoxia produces a slightly larger acute drop in arterial oxygen saturation (SpO2), particularly during the first nights of exposure. Ventilatory adaptation is somewhat different in pattern, though not in magnitude. These distinctions are real, and the literature documents them honestly. They do not, however, drive different performance outcomes when the dose is matched.

The Hbmass Comparison

The cleanest test of the two modalities is a crossover study where the same athletes complete identical LHTL protocols in both conditions. Anna Hauser and the Swiss Federal Institute of Sport group, working with Grégoire Millet's team in Lausanne, have run exactly this study at scale.

Their 2016 paper in Medicine and Science in Sports and Exercise compared 18-day LHTL camps at 2,250m under hypobaric hypoxia and normobaric hypoxia. Hbmass increased 4.5 percent in the hypobaric arm and 3.8 percent in the normobaric arm. The difference was not statistically significant (p = 0.42). The conclusion stated plainly: hypobaric and normobaric hypoxia produce similar Hbmass responses for the same hypoxic dose.

The 2017 follow-up in the Journal of Applied Physiology confirmed this with a same-subject crossover design. Fifteen male triathletes completed both modalities a year apart. The mean Hbmass increase was again similar between conditions. Notable individual variability was observed, but that variability was within-athlete rather than between-modality. Athletes who responded well to one modality also tended to respond well to the other.

The earlier 2014 Saugy et al. paper in PLoS ONE had reached the same conclusion in a parallel-group design with 27 well-trained triathletes. The haematological response was statistically equivalent across the two modalities.

This is the body of evidence direct competitors prefer not to engage with publicly. The honest reading is that for Hbmass adaptation, modality does not determine outcome. Dose does.

The Performance Comparison

If Hbmass is equivalent between modalities, performance should follow. The research confirms this.

Saugy and colleagues' 2016 paper in Frontiers in Physiology, titled "Same Performance Changes after Live High-Train Low in Normobaric vs. Hypobaric Hypoxia," reported exactly that. Sea-level 3,000m running performance improved similarly in both groups across the post-camp testing window. VO2 max responses were similar. The performance trajectory across the 21 days following the camp was indistinguishable between the two modalities.

This is the evidence the lifestyle question depends on. If the athlete is going to accumulate 300 hours of altitude exposure, the modality through which that dose is delivered does not appear to determine the performance outcome at sea level.

What Actually Differs Between the Two

Honest engagement with this topic requires acknowledging what does differ.

Acute SpO2 is lower in hypobaric hypoxia. Saugy 2014 reported that nighttime SpO2 averaged slightly lower in the hypobaric arm. The pattern is consistent with the physical reality that low atmospheric pressure adds an additional desaturation effect on top of the reduced oxygen fraction.

Ventilatory acclimatisation differs marginally. Some studies suggest a modestly different pattern of ventilatory response in the first days of exposure under hypobaric conditions, though the differences narrow as acclimatisation progresses.

Oxidative stress markers differ. A 2015 cross-over study by Debevec and colleagues found higher oxidative stress markers in the hypobaric arm compared to the normobaric arm under matched LHTL protocols. The clinical significance of this difference is not yet established, but it is a marker that the two modalities engage slightly different physiological pathways even when the haematological outcome converges.

What none of these differences do is translate into a performance gap when the dose is matched. The Hauser, Saugy, and Millet body of work has tested this question across multiple study designs and reached the same conclusion: similar Hbmass, similar performance.

Why Dose Matters More Than Modality

The recurring theme across the literature is that protocol dose drives the response, not the modality.

The dose-response curve for Hbmass is approximately 1 percent gain per 100 hours of altitude exposure at 2,300 to 3,000m, established across both natural altitude camps and simulated altitude protocols. The 300-hour total exposure benchmark applies to both. The 8 to 10 hour nightly exposure rule applies to both. The iron prerequisite applies to both.

Where dose is properly matched, modality does not appear to determine outcome. Where dose is not matched, modality is irrelevant. An athlete who runs an inadequate hypobaric camp will respond no better than one who runs an inadequate normobaric block. The protocol is what matters.

This is also why the engineering of the home altitude system carries practical weight. A normobaric system that drifts off target altitude across a six-week block is delivering an inadequate dose. The performance equivalence shown in the Hauser, Saugy, and Millet studies depends on the normobaric system delivering precisely what it claims to deliver. Box Altitude's partnership with the Queensland Academy of Sport is part of how those engineering standards have been built and verified.

The Practical Reality

The performance literature exists in dialogue with the protocol logistics literature. Both matter for any athlete planning a real altitude block.

Real altitude camps require relocation. A typical 4-week LHTL camp in Flagstaff, Boulder, Sierra Nevada, or St. Moritz costs AUD $8,000 to $15,000 for accommodation and travel alone. Most athletes can run one such camp per year, two at most. The protocol becomes a logistical project layered on top of training, work, and family.

Normobaric hypoxia at home compresses all of that into nights an athlete already spends in their own bed. The Sleep Cloud Altitude System delivers the live-high half of the protocol overnight, every night, for as long as the block requires. The training programme is unchanged. The day-to-day life is unchanged. The dose accumulates.

For athletes who want a permanent altitude environment without a tent, the Altitude Bedroom System converts the room itself into a 2,500m space. The system runs invisibly in the background, the bed remains the bed, and the protocol becomes a feature of the home rather than a seasonal disruption.

The practical case for normobaric hypoxia is not that it is superior to real altitude. It is that the performance literature shows the outcomes converge, and the access reality favours the modality that can be delivered without relocation.

Cameron Wurf, the Australian cyclist and Ironman record-holder, has spoken about how the home protocol has restructured the rhythm of his training year and the relationship between altitude blocks and race scheduling.

Where Hypobaric Still Has a Role

For athletes who already live at altitude, the question does not arise. The hypobaric environment is ambient, and the protocol is structural to where they live.

For elite athletes with sponsored access to altitude camps, hypobaric exposure during a structured camp remains common practice. The marginal physiological differences may matter at the 0.5 percent margins where Olympic medals are decided, even if those differences do not show up cleanly in controlled studies. Most elite endurance teams run a mix of hypobaric camps and normobaric home systems across a season, treating them as complementary rather than substitutes.

For everyone else, the picture is simpler. Normobaric hypoxia at home delivers the protocol. The Hauser, Saugy, and Millet body of work supports the choice. The dose is what matters.

The Bottom Line

Hauser, Saugy, and Millet have tested normobaric and hypobaric hypoxia head to head across multiple study designs. Hbmass response is similar. Performance outcomes are similar. Marginal differences exist in SpO2 trajectory, ventilatory pattern, and oxidative stress, but none of them consistently drive sea-level performance gaps when the dose is matched.

The protocol dose is what determines the response. The modality through which that dose is delivered does not appear to determine the outcome.

For athletes building a serious altitude programme, the practical question is not which modality is theoretically optimal. It is which modality allows the dose to be delivered consistently across a 4 to 6 week block without dismantling work, family, and training. For most athletes, that answer is normobaric hypoxia at home.

Explore Altitude Systems

Medical Disclaimer

The information in this article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Altitude training is a physiological intervention affecting the cardiovascular, respiratory, and haematological systems, with individual responses varying by health status, medical history, age, and fitness level. Before commencing any altitude protocol, consult a qualified medical practitioner or sports physician, particularly if you are pregnant, have cardiovascular or pulmonary conditions, haematological disorders, are recovering from surgery or injury, or are taking prescription medications. Box Altitude products are designed for healthy adults and are not medical devices intended to diagnose, treat, cure, or prevent any disease. Pre-altitude blood marker screening should be completed with a qualified clinician before starting a structured block, and any persistent severe symptoms during altitude exposure warrant immediate medical attention. Performance claims reference peer-reviewed scientific literature in healthy athletic populations; individual outcomes vary and cannot be guaranteed.